Santonocito, D.; Greco, G.; Sarpietro, M.G.; Schoubben, A.; Sciacca, C.; Romeo, G.; Mangano, K.; Puglia, C.
Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study. Int. J. Mol. Sci. 2025, 26, 11827.
https://doi.org/10.3390/ijms262411827
AMA Style
Santonocito D, Greco G, Sarpietro MG, Schoubben A, Sciacca C, Romeo G, Mangano K, Puglia C.
Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study. International Journal of Molecular Sciences. 2025; 26(24):11827.
https://doi.org/10.3390/ijms262411827
Chicago/Turabian Style
Santonocito, Debora, Giuliana Greco, Maria Grazia Sarpietro, Aurélie Schoubben, Claudia Sciacca, Giuseppe Romeo, Katia Mangano, and Carmelo Puglia.
2025. "Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study" International Journal of Molecular Sciences 26, no. 24: 11827.
https://doi.org/10.3390/ijms262411827
APA Style
Santonocito, D., Greco, G., Sarpietro, M. G., Schoubben, A., Sciacca, C., Romeo, G., Mangano, K., & Puglia, C.
(2025). Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study. International Journal of Molecular Sciences, 26(24), 11827.
https://doi.org/10.3390/ijms262411827
